Two Sigma Advisers’s MediciNova MNOV Stock Holding History

Two Sigma Advisers’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,500	Closed	-$17.7K	–	1308
2025 Q4	$17.7K	Buy	+13,500	New	+$18.6K	﹤0.01%	2317

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Two Sigma Advisers's MNOV Position: Q1 2026 in Review

Two Sigma Advisers sold out of MediciNova (MNOV) in Q1 2026, closing a stake of 13,500 shares — an estimated $17.7K sold.

Two Sigma Advisers first reported a position in MNOV in Q4 2025 and held it in 1 quarter. The position peaked at $17.7K in Q4 2025. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

Two Sigma Advisers reported no remaining MediciNova position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 13,500 MediciNova shares in Q1 2026, an estimated $17.7K.
Two Sigma Advisers first reported a position in MediciNova in Q4 2025 and held it in 1 quarter.
Two Sigma Advisers's MediciNova position peaked at $17.7K in Q4 2025.
30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.